CN104189690A - Traditional Chinese medicine preparation for relieving male prostatitis symptoms and proliferation - Google Patents
Traditional Chinese medicine preparation for relieving male prostatitis symptoms and proliferation Download PDFInfo
- Publication number
- CN104189690A CN104189690A CN201410416814.3A CN201410416814A CN104189690A CN 104189690 A CN104189690 A CN 104189690A CN 201410416814 A CN201410416814 A CN 201410416814A CN 104189690 A CN104189690 A CN 104189690A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- herba
- semen
- medicine preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention provides a traditional Chinese medicine preparation for relieving male prostatitis symptoms and proliferation. The prescription compatibility is realized by taking green tea, rhizoma imperatae, herba cepbalanoplosis segeti, Houttuynia cordata, lophatherum gracile, phaseolus calcaratus, the seed of Job's tears, peach kernel, kelp, raspberry, the fruit of Chinese wolfberry and fructus alpiniae oxyphyllae as raw materials, so that a synergistic effect is generated among the medicines, the effects of clearing heat and removing toxicity, cooling blood and reducing swelling, promoting blood circulation to remove blood stasis, resolving hard lump and reinforcing the kidney and maintaining the essence are achieved, the problems of prostatitis symptoms and proliferation can be relieved, and the traditional Chinese medicine preparation belongs to the field of traditional Chinese medicine health. The clinical test proves that the traditional Chinese medicine preparation has good effects of relieving and conditioning various prostate problems. In addition, plants with homology of medicine and food are totally taken as raw materials, so that the traditional Chinese medicine preparation does not have a toxic or side effect and has excellent nutritional values and health effects.
Description
Technical field
The present invention relates to a kind ofly for removing the Chinese medicine preparation of male prostate inflammation and hypertrophy, belong to Chinese medicine health-care field.
Background technology
Prostate is the distinctive sexual glands of male, is the property secreting gland that human body is very rare, have inside and outside dual secretory function.As exocrine gland, prostate is secreted approximately 2 milliliters of prostatic fluid every day, is the main component that forms seminal fluid; As endocrine gland, the hormone of prostate secretion is called " prostaglandin ".Prostate physiological function mainly contains four aspects: (1) exocrine function: secretion prostatic fluid is the main component that forms seminal fluid, and normospermic function is had to important function; (2) endocrine function: secretion prostaglandin, control prostatic hyperplasia; (3) control urinary function; (4) there is transportation function, control in order seminal fluid and excrete.
Prostate problems is exactly prostatitis and hyperplasia of prostate conventionally, and the two reciprocal causation, is accompanied, mostly because of in per urethra direct infection, through initiations such as blood infection cycle, lymph infection, age growth functional deteriorations.Clinical showing as mostly in various degree: urinate (1): frequent micturition, urgent micturition, dysurea, urethra scorching hot, urine retention, dripping urine, time have dysuria, nocturia to increase etc.; (2) urethra drips white: while urinating whole end or stool, urethral orifice adularescent secretions oozes; (3) pain: there are serious tenderness sense and falling inflation sense in the positions such as perineum, anus and scrotum, and often can be radiated on pubis, lumbosacral region, both sides groin, perineal position and cause lower limb pain or little distention and fullness in the abdomen; (4) physiological function changes: have premature ejaculation, seminal emission, hyposexuality or sexual impotence, sterile, part patient has painful ejaculation and hemospermia; (5) neurasthenia: insomnia and dreamful sleep, weak giddy, self-doubt sense, feels depressed, hypomnesis.
At present a lot of for the solution of prostate problems, western medicine and medical practitioners, Chinese medicine, various non-drug therapy, but all cut both ways, be difficult to eradicate, so research and development are usingd China's Chinese crude drug integration of edible and medicinal herbs as resource, the motherland's theory of medicine advantage of take product that be background, no side effects, super quality and competitive price has its huge social value and economic worth.。
Summary of the invention
The object of this invention is to provide a kind of for removing the Chinese medicine preparation of male prostate inflammation and hypertrophy.
Medicine of the present invention, to take green tea, Rhizoma Imperatae, Herba Cirsii, Herba Houttuyniae, Herba Lophatheri, Semen Phaseoli, Semen Coicis, Semen Persicae, Thallus Laminariae (Thallus Eckloniae), Fructus Rubi, Fructus Lycii, Fructus Alpiniae Oxyphyllae to carry out prescription compatibility as raw material, make the effect of each medicine produce collaborative, play altogether its heat-clearing and toxic substances removing, removing heat from blood detumescence, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, the Baconic's of reinforcing the kidney effect, thereby realize the releasing of various prostatitis and hypertrophy and take good care of effect.
Green tea, contain and the closely-related bioactive ingredients of health, not only having refreshes oneself clears away heart-fire, clearing away summer-heat, eliminate indigestion and phlegm, go greasy fat-reducing, the relieving restlessness that clears away heart-fire, removing toxic substances relieving alcoholic intoxication, promoting the production of body fluid to quench thirst, pathogenic fire reducing function of improving eyesight, and also have the clear and definite dehumidifying hot pharmacological action of dispelling.The present invention be take green tea as monarch drug, is intended to comprehensive heat-clearing and toxic substances removing, dehumidifying diuresis, and indirect action, in prostate, guarantees dauer effect.
Rhizoma Imperatae: sweet in the mouth, cold in nature; Return lung, stomach, urinary bladder channel; Cooling blood for hemostasis, clearing away heat and promoting diuresis.Herba Cirsii: sweet in the mouth, hardship, cool in nature; GUIXIN, Liver Channel; Cooling blood for hemostasis, removing blood stasis to reduce swelling.Herba Houttuyniae: cold nature, bitter in the mouth; Return lung meridian, bladder, large intestine channel; Heat-clearing and toxic substances removing, removing pus and relieving carbuncle, inducing diuresis for treating stranguria syndrome.Herba Lophatheri: sweet in the mouth, light, cold in nature; GUIXIN, stomach, small intestine meridian; Clearing heat and relieving fidgetness, dehumidifying diuresis, has inhibitory action to staphylococcus aureus, Hemolytic streptococcus.Semen Phaseoli: sweet in the mouth, acid, property is flat; GUIXIN, small intestine meridian; Inducing diuresis to remove edema, removing toxic substances and promoting pus discharge, loosening bowel to relieve constipation.Semen Coicis: slightly sweet flavor, be slightly cold, nontoxic; Enter spleen, stomach, lung, large intestine channel; Clearing away heat-damp and promoting diuresis, except rheumatism, diuresis, lung benefiting evacuation of pus, strengthening the spleen and stomach, bone and muscle strengthening.The present invention makes ministerial drug with Rhizoma Imperatae, Herba Cirsii, Herba Houttuyniae, Herba Lophatheri, Semen Phaseoli, Semen Coicis Six-element, is intended to powerful remove damp and clearing heat, removing heat from blood detumescence, removing toxic substances diuresis, and the effect of taking stopgap measures is outstanding, direct attack focus.
Semen Persicae: bitter in the mouth, sweet, property is flat; GUIXIN, liver, large intestine channel; Blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation.Thallus Laminariae (Thallus Eckloniae): salty in the mouth, cold in nature; Return liver, stomach, kidney channel; Hard masses softening and resolving, expectorant, diuretic.It is adjuvant drug that Semen Persicae, Thallus Laminariae (Thallus Eckloniae) are take in the present invention, focuses on blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, still advocates to take stopgap measures.
Fructus Rubi: sweet in the mouth, acid, warm in nature; Return kidney, urinary bladder channel; Kidney tonifying, controlling nocturnal emission with astringent drugs, reducing urination.Fructus Lycii: sweet in the mouth, property is flat; Return liver, kidney channel; Nourishing the liver and kidney, replenishing vital essence to improve eyesight.Fructus Alpiniae Oxyphyllae: acrid in the mouth, warm in nature; Return spleen, kidney channel; Tool is warming spleen and stopping diarrha takes the photograph the merit of saliva, warming the kidney reducing urination controlling nocturnal emission with astringent drugs.The present invention, is intended to the kidney invigorating, kidney tonifying, reinforces the kidney for making medicine with Fructus Rubi, Fructus Lycii, Fructus Alpiniae Oxyphyllae three, controls prostate problems originally.
Motherland's medical science is thought, kidney controlling essence storage, and main water, improving inspiration by invigorating kidney-QI, main reproduction, is " the congenital foundation ".The built-in nephroyin and nephroyang of kidney, is the residence of extreme misery, is the congenital foundation, the root of life.Kidney is hidden primordial essence Yuanyang, and primordial essence is Kidney-Yin, and Yuanyang is vigour, and nephroyin and nephroyang is in people's vital movement---from breeding to be formed into grow growth process, play decisive role.Just because of the main water of kidney, so whether the excretion of a unboiled water is normal and kidney has substantial connection.Monarch drug of the present invention is comprehensive conditioning, ministerial drug is to take stopgap measures comprehensively, and adjuvant drug is that the degree of depth takes stopgap measures, and makes medicine be to effect a permanent cure comprehensively, complete square gather altogether heat-clearing and toxic substances removing, removing heat from blood detumescence, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, the Baconic's function of reinforcing the kidney, make a concerted effort to remove alleviation prostatitis and hypertrophy problem.
The basic proportioning following (all in weight portion) of Chinese medicine preparation of the present invention: green tea 10-20 part, Rhizoma Imperatae 5-10 part, Herba Cirsii 5-10 part, Herba Houttuyniae 5-10 part, Herba Lophatheri 5-10 part, Semen Phaseoli 5-10 part, Semen Coicis 5-10 part, Semen Persicae 3-8 part, Thallus Laminariae (Thallus Eckloniae) 3-8 part, Fructus Rubi 1-5 part, Fructus Lycii 1-5 part, Fructus Alpiniae Oxyphyllae 1-5 part.
Optimum ratio: green tea 13-16 part, Rhizoma Imperatae 7-8 part, Herba Cirsii 7-8 part, Herba Houttuyniae 7-8 part, Herba Lophatheri 7-8 part, Semen Phaseoli 7-8 part, Semen Coicis 7-8 part, Semen Persicae 5-6 part, Thallus Laminariae (Thallus Eckloniae) 5-6 part, Fructus Rubi 3-4 part, Fructus Lycii 3-4 part, Fructus Alpiniae Oxyphyllae 3-4 part.
Best proportioning: 15 parts of green tea, 8 parts of Rhizoma Imperataes, 8 parts of Herba Cirsiis, 8 parts of Herba Houttuyniae, 8 parts of Herba Lophatheris, 8 parts of Semen Phaseolis, 8 parts of Semen Coiciss, 5 parts, Semen Persicae, 5 parts of Thallus Laminariae (Thallus Eckloniae)s, 3 parts of Fructus Rubies, 3 parts of Fructus Lycii, 3 parts of Fructus Alpiniae Oxyphyllae.
Chinese medicine preparation of the present invention can be prepared into various oral preparations by the common process on pharmaceutics and adjuvant.As capsule, tablet, granule, powder, pill (comprising the watered pill, honeyed pill, dragee, soft gelatin capsule, enteric coated pill or drop pill) or oral liquid.
The clinical trial data of Chinese medicine preparation of the present invention (Rhizoma Imperatae tea is red) below.
1, clinical observation object
From year April in May, 2013 to 2014, observe altogether 60 examples, the age is at 18-69 between year.1. health check-up health other side is without abnormal but be diagnosed as acute and chronic prostatitis: observe 34 examples; 2. health check-up health other side is without abnormal but be diagnosed as hyperplasia of prostate: observe 26 examples.
2, Therapeutic Method
Granules medicine of the present invention: every bag of 5g.Using method: 3 times on the one, once take 1 bag.Serveing on 30 days is a course for the treatment of, observes at most for 3 courses for the treatment of.During treatment, eat less meat product and seafood, alcohol prohibition, ban on opium-smoking and the opium trade, work and rest rule.
3, criterion: clinical manifestation all eliminate and follow up a case by regular visits to 1 year not recidivist for recovery from illness; Though eliminate more than 30% and follow up a case by regular visits to recurrence in 1 year but alleviator for effective; Other is invalid.
4, therapeutic outcome
1. acute and chronic prostatitis: recovery from illness 24 examples, account for 70.6%; Effective 10 examples, account for 29.4%; Invalid 0 example;
2. hyperplasia of prostate: recovery from illness 17 examples, account for 65.4%; Effective 7 examples, account for 26.9%; Invalid 2 examples, account for 7.7%;
3. locally during treatment be progressively eased and fade away with General Symptoms, during without uncomfortable problem generation.
Above-mentioned clinical trial proves, pharmaceutical composition of the present invention has fine treatment and opsonic action to prostate problems (inflammation, hypertrophy), and total effective rate reaches respectively 100% and 92.3%.In addition, crude drug of the present invention is the plant of integration of edible and medicinal herbs, and no side effects has good nutritive value and health care.
The specific embodiment
Below by specific embodiment, the prescription of medicine of the present invention and preparation thereof are described further.
The preparation of embodiment 1, tablet medicine of the present invention
Proportioning raw materials: 15 parts of green tea, 8 parts of Rhizoma Imperataes, 8 parts of Herba Cirsiis, 8 parts of Herba Houttuyniae, 8 parts of Herba Lophatheris, 8 parts of Semen Phaseolis, 8 parts of Semen Coiciss, 5 parts, Semen Persicae, 5 parts of Thallus Laminariae (Thallus Eckloniae)s, 3 parts of Fructus Rubies, 3 parts of Fructus Lycii, 3 parts of Fructus Alpiniae Oxyphyllae;
Preparation technology: common process and the adjuvant of preparing tablet by pharmaceutics are prepared into tablet medicine.Every 1.0g;
Usage and dosage: three times on the one, each 1.Within 30 days, be a course for the treatment of, used continuously for 3 courses for the treatment of.
The preparation of embodiment 2, capsule medicine of the present invention
Proportioning raw materials: 10 parts of green tea, 5 parts of Rhizoma Imperataes, 5 parts of Herba Cirsiis, 5 parts of Herba Houttuyniae, 5 parts of Herba Lophatheris, 5 parts of Semen Phaseolis, 5 parts of Semen Coiciss, 3 parts, Semen Persicae, 3 parts of Thallus Laminariae (Thallus Eckloniae)s, 1 part of Fructus Rubi, 1 part of Fructus Lycii, 1 part of Fructus Alpiniae Oxyphyllae;
Preparation technology: common process and the adjuvant of preparing capsule by pharmacy of Chinese materia medica are prepared into capsule medicine.Every 0.25g;
Usage and dosage: three times on the one, each 3.Within 30 days, be a course for the treatment of, used continuously for 3 courses for the treatment of.
The preparation of embodiment 3, granules medicine of the present invention
Proportioning raw materials: 20 parts of green tea, 10 parts of Rhizoma Imperataes, 10 parts of Herba Cirsiis, 10 parts of Herba Houttuyniae, 10 parts of Herba Lophatheris, 10 parts of Semen Phaseolis, 10 parts of Semen Coiciss, 8 parts, Semen Persicae, 8 parts of Thallus Laminariae (Thallus Eckloniae)s, 5 parts of Fructus Rubies, 5 parts of Fructus Lycii, 5 parts of Fructus Alpiniae Oxyphyllae;
Technique: common process and the adjuvant of preparing granule by pharmacy of Chinese materia medica are prepared into granules medicine.Every bag of 5g;
Usage and dosage: three times on the one, each 1 bag.Within 30 days, be a course for the treatment of, used continuously for 3 courses for the treatment of.
The preparation of embodiment 4, drop pill medicine of the present invention
Proportioning raw materials: 13 parts of green tea, 8 parts of Rhizoma Imperataes, 7 parts of Herba Cirsiis, 7 parts of Herba Houttuyniae, 6 parts of Herba Lophatheris, 6 parts of Semen Phaseolis, 5 parts of Semen Coiciss, 6 parts, Semen Persicae, 5 parts of Thallus Laminariae (Thallus Eckloniae)s, 4 parts of Fructus Rubies, 3 parts of Fructus Lycii, 2 parts of Fructus Alpiniae Oxyphyllae;
Preparation technology: common process and the adjuvant of preparing drop pill by pharmaceutics are prepared into drop pill medicine; Every 0.05g;
Usage and dosage: three times on the one, each 18.Within 30 days, be a course for the treatment of, used continuously for 3 courses for the treatment of.
The preparation of embodiment 5, oral medicine liquid of the present invention
Proportioning raw materials: 17 parts of green tea, 8 parts of Rhizoma Imperataes, 8 parts of Herba Cirsiis, 7 parts of Herba Houttuyniae, 7 parts of Herba Lophatheris, 5 parts of Semen Phaseolis, 5 parts of Semen Coiciss, 7 parts, Semen Persicae, 6 parts of Thallus Laminariae (Thallus Eckloniae)s, 5 parts of Fructus Rubies, 3 parts of Fructus Lycii, 1 part of Fructus Alpiniae Oxyphyllae;
Preparation technology: common process and the adjuvant of preparing oral liquid by pharmaceutics are prepared into oral liquid.Every bottle of 10ml;
Usage and dosage: three times on the one, each 10ml.Within 30 days, be a course for the treatment of, used continuously for 3 courses for the treatment of.
The preparation of embodiment 6, medicinal tea of the present invention
Proportioning raw materials: 15 parts of green tea, 8 parts of Rhizoma Imperataes, 8 parts of Herba Cirsiis, 8 parts of Herba Houttuyniae, 8 parts of Herba Lophatheris, 8 parts of Semen Phaseolis, 8 parts of Semen Coiciss, 5 parts, Semen Persicae, 5 parts of Thallus Laminariae (Thallus Eckloniae)s, 3 parts of Fructus Rubies, 3 parts of Fructus Lycii, 3 parts of Fructus Alpiniae Oxyphyllae;
Preparation technology: prepare the common process of medicinal tea and be prepared from by pharmaceutics.Every bag of 5g;
Usage and dosage: three times on the one, each 1 bag.Within 30 days, be a course for the treatment of, used continuously for 3 courses for the treatment of.
In the various embodiments described above, each proportioning raw materials is all in weight portion.
Claims (5)
1. one kind for removing the Chinese medicine preparation of male prostate inflammation and hypertrophy, that to take green tea, Rhizoma Imperatae, Herba Cirsii, Herba Houttuyniae, Herba Lophatheri, Semen Phaseoli, Semen Coicis, Semen Persicae, Thallus Laminariae (Thallus Eckloniae), Fructus Rubi, Fructus Lycii, Fructus Alpiniae Oxyphyllae be crude drug, the oral preparations being prepared into by the common process of pharmaceutics and adjuvant.
2. as claimed in claim 1 for removing the Chinese medicine preparation of male prostate inflammation and hypertrophy, it is characterized in that: described each raw material carries out proportioning by following weight portion:
Green tea 10-20, Rhizoma Imperatae 5-10 part, Herba Cirsii 5-10 part, Herba Houttuyniae 5-10 part, Herba Lophatheri 5-10 part, Semen Phaseoli 5-10 part, Semen Coicis 5-10 part, Semen Persicae 3-8 part, Thallus Laminariae (Thallus Eckloniae) 3-8 part, Fructus Rubi 1-5 part, Fructus Lycii 1-5 part, Fructus Alpiniae Oxyphyllae 1-5 part.
3. as claimed in claim 1 for removing the Chinese medicine preparation of male prostate inflammation and hypertrophy, it is characterized in that: described each crude drug carries out proportioning by following weight portion:
Green tea 13-16 part, Rhizoma Imperatae 7-8 part, Herba Cirsii 7-8 part, Herba Houttuyniae 7-8 part, Herba Lophatheri 7-8 part, Semen Phaseoli 7-8, Semen Coicis 7-8 part, Semen Persicae 5-6 part, Thallus Laminariae (Thallus Eckloniae) 5-6 part, Fructus Rubi 3-4 part, Fructus Lycii 3-4 part, Fructus Alpiniae Oxyphyllae 3-4 part.
4. as claimed in claim 1 for removing the Chinese medicine preparation of male prostate inflammation and hypertrophy, it is characterized in that: described each crude drug carries out proportioning by following weight portion:
Green tea 15,8 parts of Rhizoma Imperataes, 8 parts of Herba Cirsiis, 8 parts of Herba Houttuyniae, 8 parts of Herba Lophatheris, 8 parts of Semen Phaseolis, 8 parts of Semen Coiciss, 5 parts, Semen Persicae, 5 parts of Thallus Laminariae (Thallus Eckloniae)s, 3 parts of Fructus Rubies, 3 parts of Fructus Lycii, 3 parts of Fructus Alpiniae Oxyphyllae.
5. as claimed in claim 1 for removing the Chinese medicine preparation of male prostate inflammation and hypertrophy, it is characterized in that: described oral preparations is tablet, capsule, pill, granule, medicinal tea or oral liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410416814.3A CN104189690A (en) | 2014-08-22 | 2014-08-22 | Traditional Chinese medicine preparation for relieving male prostatitis symptoms and proliferation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410416814.3A CN104189690A (en) | 2014-08-22 | 2014-08-22 | Traditional Chinese medicine preparation for relieving male prostatitis symptoms and proliferation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104189690A true CN104189690A (en) | 2014-12-10 |
Family
ID=52075161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410416814.3A Pending CN104189690A (en) | 2014-08-22 | 2014-08-22 | Traditional Chinese medicine preparation for relieving male prostatitis symptoms and proliferation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104189690A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104958580A (en) * | 2015-06-08 | 2015-10-07 | 姚良本 | Traditional Chinese medicine composition for treating yin deficiency and fire hyperactivity type prostatitis and preparation method thereof |
| CN106474410A (en) * | 2016-12-28 | 2017-03-08 | 陕西红顶名医堂药业有限公司 | For treating Chinese medicine composition of chronic prostatitiss and preparation method thereof |
| CN107114518A (en) * | 2017-06-27 | 2017-09-01 | 贞丰县圣丰茶业综合开发有限公司 | One kind is used for prostatitic health protection tea and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102366583A (en) * | 2011-06-28 | 2012-03-07 | 赵金娥 | Traditional Chinese medicinal preparation for treating middle and old aged male diseases caused by kidney vacuity and preparation method thereof |
| CN103417860A (en) * | 2013-07-25 | 2013-12-04 | 程永冲 | Traditional Chinese herbal preparation for treating prostatitis and diseases of urinary system |
| WO2014052225A1 (en) * | 2012-09-25 | 2014-04-03 | Shiming Li | Composition for prostatic hyperplasia and prostate cancer |
-
2014
- 2014-08-22 CN CN201410416814.3A patent/CN104189690A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102366583A (en) * | 2011-06-28 | 2012-03-07 | 赵金娥 | Traditional Chinese medicinal preparation for treating middle and old aged male diseases caused by kidney vacuity and preparation method thereof |
| WO2014052225A1 (en) * | 2012-09-25 | 2014-04-03 | Shiming Li | Composition for prostatic hyperplasia and prostate cancer |
| CN103417860A (en) * | 2013-07-25 | 2013-12-04 | 程永冲 | Traditional Chinese herbal preparation for treating prostatitis and diseases of urinary system |
Non-Patent Citations (3)
| Title |
|---|
| 米建苹: "《挑针疗法》", 30 September 2012, 中国医药科技出版社 * |
| 胡艳红: "淋症的辩证施护", 《基层医学论坛》 * |
| 范绍荣: "《基层中医临证手册》", 31 October 2012, 安徽科学技术出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104958580A (en) * | 2015-06-08 | 2015-10-07 | 姚良本 | Traditional Chinese medicine composition for treating yin deficiency and fire hyperactivity type prostatitis and preparation method thereof |
| CN106474410A (en) * | 2016-12-28 | 2017-03-08 | 陕西红顶名医堂药业有限公司 | For treating Chinese medicine composition of chronic prostatitiss and preparation method thereof |
| CN107114518A (en) * | 2017-06-27 | 2017-09-01 | 贞丰县圣丰茶业综合开发有限公司 | One kind is used for prostatitic health protection tea and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104474471A (en) | Traditional Chinese medicine composition for treating thyroid | |
| CN106720815A (en) | A kind of stem of noble dendrobium coffee for nursing one's health prostatic disorders and preparation method thereof | |
| CN102188685B (en) | Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof | |
| CN102988701A (en) | Chinese medicament for treating constipation and preparation process thereof | |
| CN104189690A (en) | Traditional Chinese medicine preparation for relieving male prostatitis symptoms and proliferation | |
| CN104013900A (en) | Preparation for treating chronic enteritis | |
| CN106309828A (en) | Traditional Chinese medicine composition for treating chronic prostatitis and preparation method thereof | |
| CN103735934B (en) | A kind of medicine for the treatment of flank pain and preparation method thereof | |
| CN103251855B (en) | Traditional Chinese medicine composition for treating damp-heat-downward-flow type haemorrhoids | |
| CN102657833B (en) | Traditional Chinese medicine combination for treating puerperium fever | |
| CN104208220A (en) | Traditional Chinese medicine preparation for soothing hemorrhoid | |
| CN104757536A (en) | Brassica rapa health-care product | |
| CN102178866B (en) | Chinese medicinal preparation for dispelling damp, promoting blood circulation, softening hard mass and eliminating stagnation for people with qi-depression and blood-stagnation physique, preparation method thereof and application thereof | |
| CN103212030B (en) | Traditional Chinese medicine for treating liver depression type hyperplasia of mammary glands and preparation method thereof | |
| CN104027700A (en) | Traditional Chinese medicine composition for treating chronic prostatitis and preparation method thereof | |
| CN104225569A (en) | Chinese medicinal composition for treating chronic enteritis | |
| CN104306779A (en) | Traditional Chinese medicine decoction for treating urinary calculus | |
| CN104257898B (en) | A kind of Chinese medicine preparation for treating postpartum irregular menstruation | |
| CN102988883B (en) | Medicament for treating pneumonia and preparation method of medicament | |
| CN103638248B (en) | Medicine for treating gonarthromeningitis and preparation method of medicine | |
| CN105412825A (en) | Drug for treating hyperlipidaemia and preparation method thereof | |
| CN105435103A (en) | Traditional Chinese medicine for treatment of spleen-deficiency and phlegm-stagnation amenorrhea-galactorrhea syndrome | |
| CN104352858B (en) | A kind of Chinese medicine composition for the treatment of infantile diarrhea | |
| CN104666718A (en) | Hemangioma treatment paste | |
| CN103751628A (en) | Traditional Chinese medicine paste for treating infantile diarrhea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141210 |
|
| RJ01 | Rejection of invention patent application after publication |